🇬🇧 Anthim in United Kingdom

Anthim (OBILTOXAXIMAB) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Local brand name: Nyxthracis (previously Obiltoxaximab SFL)
  • Status: approved

Anthim in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United Kingdom

Frequently asked questions

Is Anthim approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Anthim in United Kingdom?

Elusys Therapeutics Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.